0001567619-20-017487.txt : 20201002 0001567619-20-017487.hdr.sgml : 20201002 20201002165153 ACCESSION NUMBER: 0001567619-20-017487 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201002 FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yorke Justin W CENTRAL INDEX KEY: 0001361896 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 201220867 MAIL ADDRESS: STREET 1: C/O JMG EXPLORATION STREET 2: 180 SOUTH LAKE AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 3 1 doc1.xml FORM 3 X0206 3 2020-10-02 0 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001361896 Yorke Justin W C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 1 0 0 0 Common Stock 300706 D Common Stock 264472 I By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC Stock Options (Right to Buy) 16.80 2024-06-20 Common Stock 1085 D Stock Options (Right to Buy) 16.80 2024-06-20 Common Stock 983 D Warrants (Right to Buy) 17.164 2021-05-25 Common Stock 73657 I By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years. Stock options vest upon meeting certain performance criteria. Need warrant info here. /s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact 2020-10-02 EX-24 2 poa1.htm YORKEPOA.HTM
POWER OF ATTORNEY
Know all by these presents, that, for good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the undersigned hereby constitutes and appoints Michael B. Kirwan and John J. Wolfel, and each or either of them, the undersigned’s true and lawful attorney-in-fact to:
1.  
prepare, execute in the name of the undersigned, and submit to the U.S. Securities and Exchange Commission (“SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC;
2.  
execute for and on behalf of the undersigned (in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the “Exchange Act”)), in the undersigned’s capacity as an officer and/or director of Processa Pharmaceuticals, Inc. (the “Company”), any and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary or advisable for the undersigned to file under Section 16(a) (such forms along with the Form ID are collectively, “Documents”);
3.  
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Documents and timely file such Documents with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
4.  
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the Documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact (or such attorney-in-fact’s substitute or substitutes) shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that such attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is such attorney-in-fact’s substitute or substitutes assuming, any of the undersigned’s responsibilities to comply with the Exchange Act.  The undersigned agrees to defend and hold harmless such attorney-in-fact (and such attorney-in-fact’s substitute or substitutes) from and against any and all loss, damage or liability that such attorney-in-fact may sustain as a result of any action taken in good faith hereunder.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Documents with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 14th day of February, 2020.

Signature: /s/ Justin W. Yorke
Name: Justin W. Yorke